Stock 300039 SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Kaibao Pharmaceutical CO.,Ltd

Equities

300039

CNE100000JZ3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 12/05/2024 BST 		5-day change 1st Jan Change
6.28 CNY -0.48% Intraday chart for Shanghai Kaibao Pharmaceutical CO.,Ltd -0.79% -5.56%
04-26 Shanghai Kaibao Pharmaceutical Co.,Ltd Proposes Final Dividend for the Year 2023 CI
04-25 Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,350 5,240 5,094 6,443 8,431 6,956
Enterprise Value (EV) 1 3,149 3,892 3,672 4,989 7,600 6,204
P/E ratio 19.3 x 21.1 x 48.7 x 46 x 44.2 x 21.2 x
Yield 2.46% 2% 0.62% 0.81% 0.74% 1.5%
Capitalization / Revenue 2.9 x 3.69 x 5.61 x 5.85 x 7.54 x 4.36 x
EV / Revenue 2.1 x 2.74 x 4.04 x 4.53 x 6.79 x 3.89 x
EV / EBITDA 9.32 x 12.2 x 30.5 x 32.7 x 35.8 x 18 x
EV / FCF 18.3 x 4.74 x 19.2 x 297 x 27.6 x 23.7 x
FCF Yield 5.48% 21.1% 5.21% 0.34% 3.62% 4.22%
Price to Book 1.75 x 2.04 x 1.98 x 2.12 x 2.24 x 1.73 x
Nbr of stocks (in thousands) 1,071,494 1,046,000 1,046,000 1,046,000 1,046,000 1,046,000
Reference price 2 4.060 5.010 4.870 6.160 8.060 6.650
Announcement Date 22/04/19 26/04/20 22/04/21 25/04/22 18/04/23 25/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,501 1,419 908 1,101 1,119 1,594
EBITDA 1 337.8 320.2 120.5 152.4 212.3 344.7
EBIT 1 290 272.3 80.01 119.3 181.5 309.8
Operating Margin 19.32% 19.19% 8.81% 10.84% 16.22% 19.43%
Earnings before Tax (EBT) 1 274.7 301.2 131.6 169.7 226.2 383.5
Net income 1 226.8 251 106.1 140.1 190.8 327.9
Net margin 15.11% 17.69% 11.69% 12.73% 17.05% 20.57%
EPS 2 0.2100 0.2369 0.1000 0.1340 0.1824 0.3135
Free Cash Flow 1 172.4 821.3 191.5 16.78 275 261.8
FCF margin 11.49% 57.88% 21.09% 1.53% 24.58% 16.42%
FCF Conversion (EBITDA) 51.05% 256.54% 158.93% 11.01% 129.54% 75.94%
FCF Conversion (Net income) 76.03% 327.24% 180.41% 11.98% 144.15% 79.84%
Dividend per Share 2 0.1000 0.1000 0.0300 0.0500 0.0600 0.1000
Announcement Date 22/04/19 26/04/20 22/04/21 25/04/22 18/04/23 25/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 55.11
Net margin -
EPS 2 0.0530
Dividend per Share -
Announcement Date 08/08/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,201 1,349 1,422 1,455 831 752
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 172 821 191 16.8 275 262
ROE (net income / shareholders' equity) 9.35% 9.93% 4.12% 4.98% 5.59% 8.39%
ROA (Net income/ Total Assets) 6.68% 6.09% 1.75% 2.39% 2.98% 4.38%
Assets 1 3,396 4,122 6,069 5,854 6,405 7,485
Book Value Per Share 2 2.320 2.460 2.460 2.910 3.600 3.850
Cash Flow per Share 2 0.5100 0.7700 1.250 1.290 0.6600 0.5800
Capex 1 26.1 15.5 13.9 42.5 31.6 29.1
Capex / Sales 1.74% 1.09% 1.54% 3.87% 2.83% 1.82%
Announcement Date 22/04/19 26/04/20 22/04/21 25/04/22 18/04/23 25/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD Stock Shanghai Kaibao Pharmaceutical CO.,Ltd
-5.56% 908M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.98% 682B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.39% 586B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.52% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.59% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.07% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.50% 240B
NOVARTIS AG Stock Novartis AG
+9.56% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-9.04% 203B
AMGEN INC. Stock Amgen Inc.
+7.09% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300039 Stock
  4. Financials Shanghai Kaibao Pharmaceutical CO.,Ltd